1-9 of 9
Jose L. López
Close
Sort by
Journal Articles

19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML)

Joshua J. Lara, Alfonso E. Bencomo, Mayra A. Gonzalez, Idaly M. Olivas, Jose L. Lopez, James E. Young, Vanessa V. Velazquez, Steven Glovier, Andres J. Rubio, Sara K. Dang, Jonathan Solecki, Jesse Allen, Desiree N. Tapia, Boranai Tychhon, Gonzalo E. Astudillo, Darshan S. Chandrashekar, Anna M. Eiring
Journal: Blood
Blood (2022) 140 (Supplement 1): 3381–3382.
https://doi.org/10.1182/blood-2022-162818
Published: 2022
Journal Articles

Regulation of Oxidative Energy Metabolism By G0S2 in FLT3 + AML

Mayra A. Gonzalez, Jose L. Lopez, Vanessa V. Velazquez, Mariah Perkins, Idaly M. Olivas, Alfonso E. Bencomo, Andres J. Rubio, Jehu N. Apaflo, Sudip Bajpeyi, Anna M. Eiring
Journal: Blood
Blood (2022) 140 (Supplement 1): 2984–2985.
https://doi.org/10.1182/blood-2022-155560
Published: 2022
Journal Articles

A Role for Lipid Metabolism in Tyrosine Kinase Inhibitor (TKI) Resistance of Chronic Myeloid Leukemia (CML)

Mayra A. Gonzalez, Jose L. Lopez, Katherine Schenkel, Kelaiah Reffell, Christopher A. Eide, Sudip Bajpeyi, Anna M. Eiring
Journal: Blood
Blood (2021) 138 (Supplement 1): 2542.
https://doi.org/10.1182/blood-2021-148507
Published: 2021
Journal Articles

Nilotinib Shows Safety and Efficacy in Older Patients (≥ 65 years) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase Comparable with That in Younger Patients with Chronic Myeloid Leukemia in Chronic Phase: Results From ENESTnd,

Richard A. Larson, MD, Udomsak Bunworasate, MD, Anna G. Turkina, MD, PhD, Stuart L. Goldberg, MD, Pedro Dorlhiac-Llacer, MD, Jose L. Lopez, MD, Hagop M. Kantarjian, Giuseppe Saglio, MD, Andreas Hochhaus, MD, Albert Hoenekopp, MD, Rick E. Blakesley, PhD, Richard Yu, Neil J. Gallagher, MD, PhD, Richard E. Clark, MD, Timothy P. Hughes, MD, MBBS
Journal: Blood
Blood (2011) 118 (21): 3768.
https://doi.org/10.1182/blood.V118.21.3768.3768
Published: 2011
Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Katia B. Pagnano, MD, Israel Bendit, MD, Carla Boquimpani, Carmino Antonio De Souza, MD, PhD, Eliana C M Miranda, Rosana A Silveira, Vaneuza A M Funke, MD, Ricardo Pasquini, MD, Vania Hungria, MD, Nelma Clementino, MD, Monika Conchon, Elena B Moiraghi, MD, Jose L. Lopez, MD, Carolina Pavlovsky, MD, Eduardo Cervera, Belinda Pinto Simoes, MD, PhD, Luis A Meillon, MD, Nelson Spector, MD, PhD, Nelson Hamerschlak, MD, Miguel Pavlovsky, Alicia Magarinos, MD, Vagner O Duarte, Ernesto M Fanilla, Jorge E. Cortes, Raquel Bengió, MD
Journal: Blood
Blood (2011) 118 (21): 1701.
https://doi.org/10.1182/blood.V118.21.1701.1701
Published: 2011
Journal Articles

Cardiac Safety Profile of Imatinib and Nilotinib In Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Results From ENESTnd

Richard A. Larson, MD, Andreas Hochhaus, MD, Giuseppe Saglio, MD, PhD, Gianantonio Rosti, MD, Jose L. Lopez, MD, Leif Stenke, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Stuart L. Goldberg, M.D., Ming-Chung Wang, MD, Neil J. Gallagher, MD, PhD, Albert Hoenekopp, MD, Christine-Elke Ortmann, Timothy P. Hughes, MD, MBBS, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 2291.
https://doi.org/10.1182/blood.V116.21.2291.2291
Published: 2010
Journal Articles

A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

e-blood
Beatriz Sánchez-Espiridión, Carlos Montalbán, Ángel López, Javier Menárguez, Pilar Sabín, Carmen Ruiz-Marcellán, Andrés Lopez, Rafael Ramos, Jose Rodríguez, Araceli Cánovas, Carmen Camarero, Miguel Canales, Javier Alves, Reyes Arranz, Agustín Acevedo, Antonio Salar, Sergio Serrano, Águeda Bas, Jose M. Moraleda, Pedro Sánchez-Godoy, Fernando Burgos, Concepción Rayón, Manuel F. Fresno, José García Laraña, Mónica García-Cosío, Carlos Santonja, Jose L. López, Marta Llanos, Manuela Mollejo, Joaquín González-Carrero, Ana Marín, Jerónimo Forteza, Ramón García-Sanz, Jose F. Tomás, Manuel M. Morente, Miguel A. Piris, Juan F. García, on behalf of the Spanish Hodgkin Lymphoma Study Group
Journal: Blood
Blood (2010) 116 (8): e12–e17.
https://doi.org/10.1182/blood-2010-02-270009
Published: 2010
Journal Articles

Frequency of BCR/ABL Breakpoints in CML Venezuelan Patients : Contribution to a Possible Worldwide Distribution of BCR/ABL Transcripts Associated to Ethnicity

Fanny J. Carreño, Ph.D., Jose L Lopez, MD, Estluz K Mata, LIC, Leonor Cardenas, MD, Osiris Da Costa, MD, Carlos Mendez, LIC., Rene Utrera, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 4280.
https://doi.org/10.1182/blood.V112.11.4280.4280
Published: 2008
Journal Articles

Alemtuzumab in Patients with Advanced Mycosis Fungoides and Sezary Syndrome.

Brady Beltran-Garate, MD, Henry Gomez, MD, Jose L. Lopez, MD, Mildred Borrego, MD, Mercedes Prieto, MD, Antonio A. Carrasco-Yalan, MD, Julia Huamani, PharmD, Jorge Castillo, MD, Osiris da Costa, MD
Journal: Blood
Blood (2007) 110 (11): 3425.
https://doi.org/10.1182/blood.V110.11.3425.3425
Published: 2007